Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
The current standard of care for hypothyroidism is levothyroxin e (LT4) monotherapy to reduce levels of thyrotropin (thyroid-stimulating hormone, T SH) within its reference range and amelioration of any symptoms. A substantial minority continues to report hypothyroid-like symptoms despite optimized...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2020-12-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/9/11/EC-20-0205.xml |